Drug Treatments in Development for Alzheimer's Disease

E-ISSN： 2055-2335|42|1|58-65

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.42, Iss.1, 2012-03, pp. : 58-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Treatments for Alzheimer's Disease: Shifting the Burden of Care

By Max W.

CNS Drugs, Vol. 11, Iss. 5, 1999-05 ,pp. : 363-372

Adis International

Access to resources Recommend Favorite

Mitochondrion-Specific Antioxidants as Drug Treatments for Alzheimer Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 2, 2011-03 ,pp. : 149-162

Bentham Science Publishers

Access to resources Recommend Favorite

Huprines for Alzheimer's disease drug development

By Muñoz-Torrero Diego Camps Pelayo

Expert Opinion on Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 65-81

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Thematic Issue: Alzheimer’s Disease - Mechanisms, Drug Targets and Alternative Treatments)

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-02 ,pp. : 470-471

Bentham Science Publishers

Access to resources Recommend Favorite

New and emerging treatments for Alzheimer's disease

By Corbett Anne Ballard Clive

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 2, 2012-06 ,pp. : 147-156

Informa Healthcare

Access to resources Recommend Favorite